Established with a $20M endowment in 2005, the U-M BME Coulter Translational Research Partnership Program supports research directed at promising technologies within research laboratories that are progressing towards commercial development and clinical practice.
Congratulations to the 13 teams who have been selected to receive FY26 funding through U-M BME’s Coulter Translational Research Partnership Program. Established with a $20M endowment in 2005, the U-M BME Coulter Translational Research Partnership Program supports research directed at promising technologies within research laboratories that are progressing towards commercial development and clinical practice. Outcomes of previous Coulter funding and support include the formation of 6 FDA approvals, 20 exits and more than $650 million raised in angel or venture capital.
“In this 20th anniversary year of U-M BME participating in the Coulter Translational Research Partnership Program, we are proud to be able to continue to foster these initiatives,” said Mary-Ann Mycek, William and Valerie Hall Department Chair, Biomedical Engineering and Professor, Biomedical Engineering. “On behalf of the Coulter Program’s Oversight Committee, I am delighted to congratulate these teams of engineering and clinical investigators on receiving these awards in support of their translational research projects. The Oversight Committee selected an exciting portfolio of projects from across biomedical engineering research areas, and we look forward to impactful project outcomes over the coming year.”
“The U-M BME Coulter Translational Research Program employs a proven model providing strategic planning support from the proposal stage through funding to foster translation of laboratory research towards commercial development with follow on funding,” said Thomas Marten, Managing Director, Coulter Program, Biomedical Engineering. “The 13 projects selected for funding this year are well positioned to continue the success of the program and include a wide range of novel technologies positioned for development as drugs or medical devices.”
Read more about the 20-year history of U-M BME’s Coulter Translational Research Partnership Program.